1. Home
  2. DCTH vs CPS Comparison

DCTH vs CPS Comparison

Compare DCTH & CPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • CPS
  • Stock Information
  • Founded
  • DCTH 1988
  • CPS 1960
  • Country
  • DCTH United States
  • CPS United States
  • Employees
  • DCTH N/A
  • CPS N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • CPS Auto Parts:O.E.M.
  • Sector
  • DCTH Health Care
  • CPS Consumer Discretionary
  • Exchange
  • DCTH Nasdaq
  • CPS Nasdaq
  • Market Cap
  • DCTH 388.3M
  • CPS 462.2M
  • IPO Year
  • DCTH N/A
  • CPS N/A
  • Fundamental
  • Price
  • DCTH $8.62
  • CPS $28.94
  • Analyst Decision
  • DCTH Strong Buy
  • CPS Buy
  • Analyst Count
  • DCTH 5
  • CPS 2
  • Target Price
  • DCTH $22.60
  • CPS $26.50
  • AVG Volume (30 Days)
  • DCTH 1.3M
  • CPS 264.2K
  • Earning Date
  • DCTH 11-04-2025
  • CPS 10-30-2025
  • Dividend Yield
  • DCTH N/A
  • CPS N/A
  • EPS Growth
  • DCTH N/A
  • CPS N/A
  • EPS
  • DCTH 0.03
  • CPS 1.84
  • Revenue
  • DCTH $79,603,000.00
  • CPS $2,729,297,000.00
  • Revenue This Year
  • DCTH $135.11
  • CPS $2.79
  • Revenue Next Year
  • DCTH $36.30
  • CPS $3.60
  • P/E Ratio
  • DCTH $250.39
  • CPS $15.57
  • Revenue Growth
  • DCTH 251.54
  • CPS N/A
  • 52 Week Low
  • DCTH $8.39
  • CPS $10.38
  • 52 Week High
  • DCTH $18.23
  • CPS $40.67
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 30.11
  • CPS 35.89
  • Support Level
  • DCTH $9.15
  • CPS $27.11
  • Resistance Level
  • DCTH $10.03
  • CPS $39.75
  • Average True Range (ATR)
  • DCTH 0.67
  • CPS 2.03
  • MACD
  • DCTH -0.21
  • CPS -0.90
  • Stochastic Oscillator
  • DCTH 5.71
  • CPS 16.61

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

About CPS Cooper-Standard Holdings Inc.

Cooper-Standard Holdings Inc is engaged in the manufacture of sealing and fluid handling systems (consisting of fuel and brake delivery systems and fluid transfer systems). Its products are designed for passenger vehicles and light trucks that are manufactured by automotive original equipment manufacturers (OEMs) and replacement markets. It has two reportable segments: Sealing Systems and Fluid Handling Systems. The group's geographic regions are North America, Europe, Asia Pacific, and South America.

Share on Social Networks: